rs369232492
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000349.3(STAR):c.544C>T(p.Arg182Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000349.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STAR | ENST00000276449.9 | c.544C>T | p.Arg182Cys | missense_variant | 5/7 | 1 | NM_000349.3 | ENSP00000276449.3 | ||
STAR | ENST00000522050.1 | c.478C>T | p.Arg160Cys | missense_variant | 4/5 | 5 | ENSP00000429009.1 | |||
STAR | ENST00000520114.1 | n.1031C>T | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251304Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135886
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461872Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 727238
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74364
ClinVar
Submissions by phenotype
Congenital lipoid adrenal hyperplasia due to STAR deficency Pathogenic:6
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 03, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 29, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | Jun 02, 2023 | The observed missense c.544C>T(p.Arg182Cys) variant in STAR gene has been reported previously in homoygous and compound heterozygous state in multiple individuals affected with lipoid adrenal hyperplasia (Park HW, et al., 2013; Ishizu K, et al., 2008; Joshi R, et al., 2014). The p.Arg182Cys variant has been reported with allele frequency of 0.001% in gnomAD Exomes. This variant has been reported to the ClinVar database as Likely Pathogenic / Pathogenic (multiple submissions). The amino acid change p.Arg182Cys in STAR is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 182 is changed to a Cys changing protein sequence and it might alter its composition and physico-chemical properties. Another missense variant c.545G>A (p.Arg182His) on the same residue has been reported previously to be Pathogenic (Chen X, et al., 2005), suggesting that this residue might be of clinical significance. For these reasons, this variant has been classified as Pathogenic. In absence of another reportable variant in STAR gene, the molecular diagnosis is not confirmed. The same variant in STAR gene was previously detected in heterozygous state in mother [Mrs. SALLA LAKSHANA, id: 30406300477]. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jan 31, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Apr 04, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.91; 3Cnet: 0.99). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000550550). A different missense change at the same codon (p.Arg182His) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000008995). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 19, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg182 amino acid residue in STAR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11509019, 15546900). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt STAR protein function. ClinVar contains an entry for this variant (Variation ID: 550550). This missense change has been observed in individual(s) with lipoid adrenal hyperplasia (PMID: 16118340, 24790358, 24904850). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs369232492, gnomAD 0.006%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 182 of the STAR protein (p.Arg182Cys). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at